Axon Enterprise, Inc $AXON Holdings Raised by Maryland State Retirement & Pension System

Maryland State Retirement & Pension System lifted its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 6,258.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 260,804 shares of the biotechnology company’s stock after buying an additional 256,702 shares during the quarter. Axon Enterprise makes up 1.7% of Maryland State Retirement & Pension System’s holdings, making the stock its 7th largest holding. Maryland State Retirement & Pension System owned about 0.32% of Axon Enterprise worth $110,195,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Cabot Wealth Management Inc. lifted its stake in Axon Enterprise by 11,781.7% in the third quarter. Cabot Wealth Management Inc. now owns 223,139 shares of the biotechnology company’s stock worth $94,281,000 after acquiring an additional 221,261 shares during the period. Ritholtz Wealth Management grew its holdings in Axon Enterprise by 10,951.5% during the 3rd quarter. Ritholtz Wealth Management now owns 220,257 shares of the biotechnology company’s stock worth $93,063,000 after acquiring an additional 218,264 shares in the last quarter. UNIVEST FINANCIAL Corp purchased a new position in Axon Enterprise during the 3rd quarter valued at about $12,961,000. NBH Bank increased its position in Axon Enterprise by 5,493.8% during the 3rd quarter. NBH Bank now owns 10,908 shares of the biotechnology company’s stock valued at $4,609,000 after purchasing an additional 10,713 shares during the period. Finally, First Command Advisory Services Inc. increased its position in Axon Enterprise by 10,431.1% during the 3rd quarter. First Command Advisory Services Inc. now owns 7,793 shares of the biotechnology company’s stock valued at $3,293,000 after purchasing an additional 7,719 shares during the period. Institutional investors own 79.08% of the company’s stock.

Recent Axon Enterprise Headlines

Investors following AXON have been watching these headlines:

• Positive Sentiment: Northland maintained a $540 price target despite Axon’s steep decline from its August high, signaling that at least one analyst sees meaningful potential upside. A price target is an estimate, not a guarantee. Axon Is Down 52% From Its August High. Northland Still Sees $540
• Negative Sentiment: Axon’s third-quarter adjusted EPS missed Wall Street expectations, and cautious guidance contributed to a sharp share decline. The company also said federal contract delays shifted $130 million of revenue out of 2026, weighing on near-term expectations. Axon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?
• Negative Sentiment: Several law firms have announced investigations into potential securities-law claims related to Axon’s earnings report. These are allegations under investigation, not findings of wrongdoing, but add a source of uncertainty for investors. Levi & Korsinsky investor investigation notice

Axon Enterprise Price Performance

Shares of AXON stock opened at $315.42 on Thursday. The stock’s 50-day moving average is $426.24 and its 200 day moving average is $470.65. Axon Enterprise, Inc has a 1-year low of $291.45 and a 1-year high of $665.07. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.00 and a quick ratio of 2.60. The company has a market cap of $25.68 billion, a P/E ratio of 101.10, a PEG ratio of 5.75 and a beta of 1.48.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Thursday, November 5th. The biotechnology company reported $1.72 EPS for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). The firm had revenue of $908.55 million during the quarter, compared to the consensus estimate of $934.33 million. Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The business’s revenue for the quarter was up 27.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.17 earnings per share. Research analysts predict that Axon Enterprise, Inc will post 2.10 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Isaiah Fields sold 1,017 shares of Axon Enterprise stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $480.45, for a total value of $488,617.65. Following the transaction, the insider owned 56,264 shares of the company’s stock, valued at $27,032,038.80. The trade was a 1.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey Kunins sold 9,605 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the transaction, the insider owned 97,761 shares of the company’s stock, valued at approximately $61,266,818.70. This trade represents a 8.95% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 37,397 shares of company stock valued at $21,234,034 over the last 90 days. 4.20% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts have recently commented on AXON shares. TD Cowen reduced their price target on shares of Axon Enterprise from $825.00 to $800.00 and set a “buy” rating for the company in a report on Monday, October 26th. Piper Sandler reiterated an “overweight” rating and set a $540.00 price objective (down from $561.00) on shares of Axon Enterprise in a research note on Friday, November 6th. Argus lifted their price objective on shares of Axon Enterprise from $460.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, September 3rd. JPMorgan Chase & Co. cut their price objective on shares of Axon Enterprise from $755.00 to $610.00 and set an “overweight” rating on the stock in a report on Friday, November 6th. Finally, UBS Group boosted their price objective on shares of Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a research note on Thursday, August 6th. Thirteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus target price of $612.18.

Axon Enterprise Profile

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.